Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 17
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A fossil leaf site west of Ellensburg: part of the Ellensburg Flora? Or its own thing?

    An ash-laden fossil leaf deposit in Central Washington assigned to the Ellensburg Flora (12 to 10 million years...

    How has a Hemileuca moth evolved to live in a unique coastal Texas ecosystem?

    We are studying a population of moths in an unique oak ecosystem in a coastal barrier island environment to...

    Backer Badge Funded